NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

支氣管鏡市場 - 預測(2021年∼2026年)

Bronchoscope Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023149
出版日期 內容資訊 英文 121 Pages
商品交期: 最快1-2個工作天內
價格
支氣管鏡市場 - 預測(2021年∼2026年) Bronchoscope Market - Forecasts from 2021 to 2026
出版日期: 2021年07月13日內容資訊: 英文 121 Pages
簡介

全球支氣管鏡的市場規模,2019年價值2億8,141萬4,000美元。支氣管鏡是一種透過鼻子或嘴巴插入的醫療器械,可讓醫生查看、檢查和治療呼吸道或肺部。進行支氣管鏡檢查以診斷肺部疾病、腫瘤、慢性咳嗽、感染或其他肺部疾病。市場主要受肺癌、COPD 和呼吸道感染等呼吸道疾病發病率上升的推動,預計在評估期間,這些疾病將激增對支氣管鏡的需求。此外,預計微創手術的日益普及和需求將在未來幾年推動全球支氣管鏡市場的成長。然而,支氣管鏡的高成本和與支氣管鏡檢查程序相關的感染風險可能會在預測期內抑制市場的成長。

本報告提供支氣管鏡的市場調查,市場概要,市場成長要素及阻礙因素,競爭情形,各類型、各實用性、各應用領域、各終端用戶、各地區的市場分析,並提供主要企業簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 終端用戶的交易
    • 購買企業的交易
    • 新加入業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的競爭情形
  • 產業的價值鏈分析

第5章 各類型:支氣管鏡的全球市場分析

  • 簡介
  • 軟性支氣管鏡
  • 硬式支氣管鏡

第6章 各實用性:支氣管鏡的全球市場分析

  • 簡介
  • 拋棄式
  • 可重複使用

第7章 各應用領域:支氣管鏡的全球市場分析

  • 簡介
  • 診斷
  • 治療

第8章 各終端用戶:支氣管鏡的全球市場分析

  • 簡介
  • 醫院及診療所
  • 門診病人手術中心
  • 診斷中心

第9章 各地區:支氣管鏡的全球市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第10章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,及共同研究
  • 供應商的競爭力矩陣

第11章 企業簡介

  • Boston Scientific Corporation
  • Olympus Corporation
  • Richard Wolf GmbH
  • PENTAX Medical
  • NeoScope Inc.
  • Ambu A/S
  • KARL STORZ
  • Fujifilm Holdings Corporation
  • Lymol Medical
  • Novatech SA
目錄
Product Code: KSI061611833

The global bronchoscope market is evaluated at US$281.414 million for the year 2019. A bronchoscope is a medical instrument that is inserted through the nose or mouth and allows the doctor to view, examine and treat the airways or lungs. A bronchoscopy is performed to diagnose lung disease, tumor, chronic cough, infection, or other diseases of the lungs. The device is also used to remove obstructions or tumors from the air passages or lungs or to place a small tube to hold open an airway (stent). The market is majorly driven by rising incidences of the respiratory tract diseases such as lung cancer, COPD, and respiratory tract infections, which are anticipated to surge the demand for bronchoscopes during the assessment period. Also, the growing adoption and demand for minimally invasive surgeries are projected to boost the growth of the global bronchoscope market in the coming years. However, the high cost of bronchoscopes and the risk of infection associated with the bronchoscopy procedures might restrain the growth of the market during the forecast period.

The recent outbreak of the novel coronavirus disease had a positive impact on the global bronchoscope market. The pandemic shifted the major focus of the healthcare system towards COVID-19 and as part of the COVID-19 restrictions, a large number of procedures and surgeries had to be canceled in many parts of the world, which led to a decline in the global bronchoscope market in 2020. Although bronchoscopy was performed in COVID-19 patients with severe respiratory illness, the decline in the number of bronchoscopy procedures was greater. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.

Rising prevalence of respiratory diseases.

According to the Global Burden of Disease Study 2017 by the Institute for Health Metrics and Evaluation (IHME), the prevalence of chronic respiratory disease increased by around 40% from 1990 to 2017 with an estimated 545 billion people suffering from chronic respiratory disease in 2017. Also, an estimated 3.9 million people died due to chronic respiratory diseases in 2017 and witnessed a surge of 18% since 1990. Chronic respiratory disease causes the third most number of deaths in the world and is just behind cardiovascular diseases and neoplasms. Forum of International Respiratory Societies states that nearly 65 million people suffer from chronic obstructive pulmonary disease (COPD) while 3 million die from it each year. Also, asthma is the most common disease in children worldwide and affects 14% of the children globally, while the total number of asthma patients is 334 million. The cases of asthma in children are increasing over the years. This rise has made the role of bronchoscopes even more prominent in diagnosing and treating respiratory diseases, which is anticipated to propel the growth of the global bronchoscope market during the forecast period.

Growing demand for minimally invasive surgeries.

The rise in the adoption and demand for minimally invasive surgeries, due to its various advantages over traditional surgeries, is prompting increased use of Bronchoscope which is anticipated to propel the growth of the global Bronchoscope market during the forecast period. The minimally invasive surgery requires smaller incisions and consequently less scarring which are some of the reasons for its rising preference. The minimally invasive surgeries reduce the hospital stay time for the patient and have shorter recovery periods, along with providing increased accuracy, which is prompting the demand for minimally invasive surgeries. Another article published in February 2020 in US NLM, NIH, showed that the open surgical procedures declined by nearly 35% from 2000 to 2018 and are being replaced by minimally invasive surgeries. This rising demand is expected to grow further in the coming years and is anticipated to boost the global Bronchoscope market growth during the forecast period.

North America to hold a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to a large presence of chronic respiratory diseases and lung cancer. Also, the widespread adoption of minimally invasive surgeries in the region, along with favorable reimbursement policies is projected to boost the growth of the bronchoscope market in North America. The Asia Pacific region is anticipated to witness substantial growth due to increased investment in healthcare leading to the availability of requisite healthcare facilities in the region. Also, a surge in the number of lung cancer cases and a rise in respiratory diseases due to high levels of pollution in countries like China and India is further anticipated to propel the market growth in the Asia Pacific region during the forecast period.

Market Segmentation:

  • By Type

Flexible Bronchoscope

Rigid Bronchoscope

  • By Usability

Single-Use

Reusable

  • By Application

Diagnostic

Therapeutic

  • By End-User

Hospitals and Clinics

Ambulatory Surgical Centers

Diagnostic Centers

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Global Bronchoscope Market Analysis, by Type

  • 5.1. Introduction
  • 5.2. Flexible Bronchoscope
  • 5.3. Rigid Bronchoscope

6. Global Bronchoscope Market Analysis, by Usability

  • 6.1. Introduction
  • 6.2. Single-Use
  • 6.3. Reusable

7. Global Bronchoscope Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Diagnostic
  • 7.3. Therapeutic

8. Global Bronchoscope Market Analysis, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals and Clinics
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Diagnostic Centers

9. Global Bronchoscope Market Analysis, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. UK
    • 9.4.4. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Taiwan
    • 9.6.6. Thailand
    • 9.6.7. Indonesia
    • 9.6.8. Others

10. Competitive Environment and Analysis

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. Company Profiles

  • 11.1. Boston Scientific Corporation
  • 11.2. Olympus Corporation
  • 11.3. Richard Wolf GmbH
  • 11.4. PENTAX Medical
  • 11.5. NeoScope Inc.
  • 11.6. Ambu A/S
  • 11.7. KARL STORZ
  • 11.8. Fujifilm Holdings Corporation
  • 11.9. Lymol Medical
  • 11.10. Novatech SA